Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with Target = 'Epidermal growth factor receptor [1-772,'NPH',773-1210]'
TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557849(US11365189, Ex. No. 3 | 1-(3-((4-((3,4-dichlorophe...)
Affinity DataIC50: 2.40nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557852(US11365189, Ex. No. 6 | 1-(3-((4-((3,4-dichloro-2-...)
Affinity DataIC50: 2.80nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557850(US11365189, Ex. No. 4 | 6-((1-acryloylpiperidin-4-...)
Affinity DataIC50: 5.90nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557858(US11365189, Ex. No. 14 | 6-((1-acryloylpiperidin-4...)
Affinity DataIC50: 15nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557851(US11365189, Ex. No. 5 | 1-(3-((4-((2,4-dichlorophe...)
Affinity DataIC50: 16nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557846(US11365189, Ex. No. 1 | 1-(4-((4-((2,4-dichlorophe...)
Affinity DataIC50: 48nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557861(US11365189, Ex. No. 16 | 6-((1-acryloylpiperidin-4...)
Affinity DataIC50: 190nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557860(US11365189, Ex. No. 15 | 6-((1-acryloylpiperidin-4...)
Affinity DataIC50: 250nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557848(US11365189, Ex. No. 2 | 1-(3-((4-((2,4-dichlorophe...)
Affinity DataIC50: 390nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557855(US11365189, Ex. No. 11 | 6-((1-acryloylpiperidin-4...)
Affinity DataIC50: 410nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557856(US11365189, Ex. No. 12 | 6-((1-acryloylpiperidin-4...)
Affinity DataIC50: 2.60E+3nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-772,'NPH',773-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557864(US11365189, Ex. No. 20 | 6-((1-acryloylpiperidin-4...)
Affinity DataIC50: 3.00E+3nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent